Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-24-002024
Filing Date
2024-10-07
Accepted
2024-10-07 11:37:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G 6480
  Complete submission text file 0000315066-24-002024.txt   8438
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 241356667
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)